BR112021021390A2 - Sistema de distribuição de vitaminas lipossolúveis - Google Patents

Sistema de distribuição de vitaminas lipossolúveis

Info

Publication number
BR112021021390A2
BR112021021390A2 BR112021021390A BR112021021390A BR112021021390A2 BR 112021021390 A2 BR112021021390 A2 BR 112021021390A2 BR 112021021390 A BR112021021390 A BR 112021021390A BR 112021021390 A BR112021021390 A BR 112021021390A BR 112021021390 A2 BR112021021390 A2 BR 112021021390A2
Authority
BR
Brazil
Prior art keywords
fat
delivery system
soluble vitamin
vitamin delivery
soluble vitamins
Prior art date
Application number
BR112021021390A
Other languages
English (en)
Portuguese (pt)
Inventor
Elger Funda
Odile Krainz
Robert Steinert
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BR112021021390A2 publication Critical patent/BR112021021390A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR112021021390A 2019-04-30 2020-04-09 Sistema de distribuição de vitaminas lipossolúveis BR112021021390A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19171752 2019-04-30
PCT/EP2020/060161 WO2020221572A1 (en) 2019-04-30 2020-04-09 New delivery system for fat soluble vitamins

Publications (1)

Publication Number Publication Date
BR112021021390A2 true BR112021021390A2 (pt) 2021-12-21

Family

ID=66429183

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021021390A BR112021021390A2 (pt) 2019-04-30 2020-04-09 Sistema de distribuição de vitaminas lipossolúveis

Country Status (7)

Country Link
US (1) US12419841B2 (https=)
EP (1) EP3962461A1 (https=)
JP (1) JP7657725B2 (https=)
KR (1) KR20220003039A (https=)
CN (1) CN113727706A (https=)
BR (1) BR112021021390A2 (https=)
WO (1) WO2020221572A1 (https=)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389419A (en) * 1980-11-10 1983-06-21 Damon Corporation Vitamin encapsulation
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JP2939403B2 (ja) * 1993-02-05 1999-08-25 義秀 萩原 プロラクチン又は成長ホルモンの分泌促進剤
US6620431B1 (en) * 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
US7097868B2 (en) * 2001-08-23 2006-08-29 Bio-Dar Ltd. Stable coated microcapsules
JP4593846B2 (ja) * 2001-09-07 2010-12-08 信越化学工業株式会社 医薬品又は食品用マイクロカプセルの製造方法
JP2004168703A (ja) 2002-11-20 2004-06-17 Shin Etsu Chem Co Ltd マイクロカプセル及びその製造方法
EP1940249B1 (en) * 2005-10-21 2015-06-03 DSM IP Assets B.V. Novel formulations of fat-soluble active ingredients with high bioavailability
US20070098790A1 (en) 2005-10-31 2007-05-03 David Jiang Nutritional supplement for the enhancement of the health of the liver
JP2010121028A (ja) 2008-11-19 2010-06-03 Ina Food Industry Co Ltd 改質キサンタンガム、改質アラビアガム、及び改質タマリンドシードガム、並びにキサンタンガム、アラビアガム、及びタマリンドシードガムの架橋方法
US9609885B2 (en) * 2011-10-14 2017-04-04 Dsm Ip Assets B.V. Coating system
US20160158174A1 (en) 2014-12-09 2016-06-09 Intercontinental Great Brands Llc Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
JP6659075B2 (ja) 2014-12-26 2020-03-04 ポーラ化成工業株式会社 カプセル体及びその製造方法
US20170296476A1 (en) * 2016-04-15 2017-10-19 Grünenthal GmbH Modified release abuse deterrent dosage forms
US11771656B2 (en) 2016-11-17 2023-10-03 Shanghai Jiaotong University School Of Medicine Oral colon-targeted delivery system and preparation method and application thereof
JP2020536930A (ja) * 2017-10-13 2020-12-17 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 放出調節乱用防止剤形
CN109511785A (zh) * 2018-12-25 2019-03-26 乐山市瑞和祥动物保健药业有限公司 一种兽用复合维生素微丸及其制备方法

Also Published As

Publication number Publication date
US20220226254A1 (en) 2022-07-21
KR20220003039A (ko) 2022-01-07
CN113727706A (zh) 2021-11-30
EP3962461A1 (en) 2022-03-09
JP7657725B2 (ja) 2025-04-07
US12419841B2 (en) 2025-09-23
WO2020221572A1 (en) 2020-11-05
JP2022530307A (ja) 2022-06-29

Similar Documents

Publication Publication Date Title
BR112021016198A2 (pt) Formulações de anticorpo anti-il-36r
NI201800038S (es) Dispositivo de administración de medicamento intranasal
BR112017027843A2 (pt) formulações farmacêuticas compreendendo tenofovir e emtricitabina
UY34698A (es) Combinaciones farmacéuticas que comprenden un análogo de tionucleótidos
BR112019003577A2 (pt) métodos de tratamento da semente e produtos resultantes
CL2019001337A1 (es) Formulaciones farmacéuticas.
MX2014008782A (es) Sistema de administracion por via transmucosa para un medicamento farmaceutico.
CU20210077A7 (es) Extractos bacterianos estables como fármacos
BR112021021429A2 (pt) Sistema de distribuição para vitaminas específicas solúveis em água
CO2017007316A2 (es) Formulación farmacéutica
MX2022003639A (es) Sistemas y métodos de suministro de fármacos.
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
MX2019010330A (es) Formulaciones con mejora de la estabilidad.
BR112017001749A2 (pt) tipos de álcool polivinílico em pó, diretamente comprimíveis
MX2020005472A (es) Sistemas de administración de fármacos a base de maitansinoide.
BR112018011476A2 (pt) formulação de vitamina
JOP20210063A1 (ar) مشتقات جديدة من أمينو- بيريميدونيل- بيبريدينيل، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها
BR112016028192A2 (pt) gerritdina g. schoonus-gerritsma
DK4027973T3 (da) Formuleringer til lægemiddeladministration
BR112021021390A2 (pt) Sistema de distribuição de vitaminas lipossolúveis
PH12016501733A1 (en) Pharmaceutical composition for preventing or treating skin rash
EP4520347A3 (en) A pharmaceutical composition
MX2018010434A (es) Composiciones farmaceuticas disuasivas del abuso.
PH12017500943A1 (en) Formulation for effective tocotrienol delivery
GT201400115A (es) Combinación farmacéutica antineurítica y composición

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]